ORTHOCELL LIMITED — Director's Dealing 2017

Aug 7, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Orthocell Limited

ABN 57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Paul Anderson
Date of last notice	25/07/2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct and Indirect	Direct and Indirect	Direct and Indirect	Direct and Indirect	Direct and Indirect
	Nature of indirect interest						Mr Anderson is a trustee and beneficiary of th
	(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
	Date of chane						03/08/2017
		g
	No. of	securities held	prior to change
	Paul Anderson and Nicole TelfordPaul Anderson
	Nicole Telford							250,000 Unlisted Option or before 24 Nove250,000 Unlisted optio		ons exercisable atmber 2017ns exercisable at $
								on or before 12 Octo		er 2019
	Paul Anderson and Nicole T<The Elwing Superannuatio(Mr Anderson is a trustee and			elfordn Fund>eneficiar of the				578,619 Ordinary Sh1,750,000 Unlisted opat $0.50 expiring 3 Au		restions exercisablegust 2017
	Elwing Superannuation Fund)			y				13,692 Unlisted Warron or before 19 Nove		ants exercisable atmber 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Unlisted options
Number acquired	-
Number disposed	1,750,000
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	-
No. of securities held after changePaul Anderson and Nicole TelfordPaul AndersonNicole TelfordPaul Anderson and Nicole Telford(Mr Anderson is a trustee and beneficiary of theElwing Superannuation Fund)	6,403,335 Ordinary Shares16 Ordinary Shares750,000 Unlisted Options exercisable at $0.62on or before 24 November 2017250,000 Unlisted Options exercisable at $0.62on or before 24 November 2017250,000 Unlisted options exercisable at $0.624on or before 12 October 2019578,619 Ordinary Shares13,692 Unlisted Warrants exercisable at $0.58on or before 19 November 2020
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	Expiry of Unlisted Options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	N/A

• See chapter 19 for defined terms.

Appendix 2

3Y

Page

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	N/A
Interest after change	N/A

Part 3 Closed Period

Part 3 Closed Period
Were the interests in the securities orcontracts detailed above traded during a+closed period where prior written clearancewas required?	No
If so, was prior written clearance provided toallow the trade to proceed during this period?	N/A
If prior written clearance was provided, onwhat date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3